Related Experiment Video
Updated: Aug 15, 2026
09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Summary
Carcinomas express T and Tn antigens, which are masked in normal tissues. These tumor-associated antigens trigger immune responses, aiding in early carcinoma detection and diagnosis.
Area of Science:
- Oncology
- Immunology
- Glycobiology
Background:
- Primary and metastatic carcinomas are the most common human malignant tumors, originating from epithelial cells.
- T and Tn antigens are typically masked in healthy tissues but become exposed and immunoreactive in most carcinomas.
- These exposed antigens are recognized as foreign by the patient's immune system, suggesting a role in cancer pathogenesis.
Purpose of the Study:
- To investigate the role of T and Tn antigens in carcinoma diagnosis and prognosis.
- To explore the potential of T and Tn antigens as biomarkers for early cancer detection.
- To understand the clinical and pathogenic consequences of T and Tn antigen expression in carcinomas.
Main Methods:
- Synthesis of T and Tn antigen epitopes.
- Immune response assays to measure patient autoimmune responses to T antigen.
- Analysis of T and Tn antigen expression correlation with carcinoma differentiation and invasion.
Main Results:
- Carcinomas exhibit uncovered and immunoreactive T and Tn antigens, unlike normal tissues where they are masked.
- Strong autoimmune responses to T antigen are observed in most carcinoma patients, enabling sensitive and specific detection.
- The extent of T and Tn antigen expression correlates with carcinoma differentiation and may be involved in tumor invasion.
Conclusions:
- T and Tn antigens serve as powerful histological markers for carcinoma diagnosis and prognosis.
- Immune responses to T antigen offer a sensitive and specific method for early carcinoma detection.
- The expression patterns of T and Tn antigens provide insights into carcinoma pathogenesis, including invasion and differentiation.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.